153 related articles for article (PubMed ID: 17909076)
21. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
[TBL] [Abstract][Full Text] [Related]
22. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study.
Schatz J; Schlenz AM; Smith KE; Roberts CW
Dev Med Child Neurol; 2018 May; 60(5):520-526. PubMed ID: 29488622
[TBL] [Abstract][Full Text] [Related]
23. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Gill FM; Sleeper LA; Weiner SJ; Brown AK; Bellevue R; Grover R; Pegelow CH; Vichinsky E
Blood; 1995 Jul; 86(2):776-83. PubMed ID: 7606007
[TBL] [Abstract][Full Text] [Related]
24. Low-risk factors for severe bacterial infection and acute chest syndrome in children with sickle cell disease.
Rincón-López EM; Navarro Gómez ML; Hernández-Sampelayo Matos T; Saavedra-Lozano J; Aguilar de la Red Y; Hernández Rupérez B; Cela de Julián E;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27667. PubMed ID: 30740900
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
26. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
Scothorn DJ; Price C; Schwartz D; Terrill C; Buchanan GR; Shurney W; Sarniak I; Fallon R; Chu JY; Pegelow CH; Wang W; Casella JF; Resar LS; Berman B; Adamkiewicz T; Hsu LL; Ohene-Frempong K; Smith-Whitley K; Mahoney D; Scott JP; Woods GM; Watanabe M; Debaun MR
J Pediatr; 2002 Mar; 140(3):348-54. PubMed ID: 11953734
[TBL] [Abstract][Full Text] [Related]
27. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.
Miller ST; Macklin EA; Pegelow CH; Kinney TR; Sleeper LA; Bello JA; DeWitt LD; Gallagher DM; Guarini L; Moser FG; Ohene-Frempong K; Sanchez N; Vichinsky EP; Wang WC; Wethers DL; Younkin DP; Zimmerman RA; DeBaun MR;
J Pediatr; 2001 Sep; 139(3):385-90. PubMed ID: 11562618
[TBL] [Abstract][Full Text] [Related]
28. Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes.
Silva IV; Reis AF; Palaré MJ; Ferrão A; Rodrigues T; Morais A
Eur J Haematol; 2015 Feb; 94(2):157-61. PubMed ID: 25039473
[TBL] [Abstract][Full Text] [Related]
29. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
Tshilolo L; Tomlinson G; Williams TN; Santos B; Olupot-Olupot P; Lane A; Aygun B; Stuber SE; Latham TS; McGann PT; Ware RE;
N Engl J Med; 2019 Jan; 380(2):121-131. PubMed ID: 30501550
[TBL] [Abstract][Full Text] [Related]
31. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.
Strouse JJ; Hulbert ML; DeBaun MR; Jordan LC; Casella JF
Pediatrics; 2006 Nov; 118(5):1916-24. PubMed ID: 17079562
[TBL] [Abstract][Full Text] [Related]
32. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
Jones A; Granger S; Brambilla D; Gallagher D; Vichinsky E; Woods G; Berman B; Roach S; Nichols F; Adams RJ
Pediatr Radiol; 2005 Jan; 35(1):66-72. PubMed ID: 15517239
[TBL] [Abstract][Full Text] [Related]
33. Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment.
Wethers DL
Am Fam Physician; 2000 Sep; 62(6):1309-14. PubMed ID: 11011859
[TBL] [Abstract][Full Text] [Related]
34. Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia.
Uong EC; Boyd JH; DeBaun MR
J Pediatr; 2006 Nov; 149(5):707-9. PubMed ID: 17095349
[TBL] [Abstract][Full Text] [Related]
35. Neurodevelopmental deficits among infants and toddlers with sickle cell disease.
Glass P; Brennan T; Wang J; Luchtman-Jones L; Hsu L; Bass CM; Rana S; Martin B; Reed C; Cheng YI; Gordeuk V
J Dev Behav Pediatr; 2013; 34(6):399-405. PubMed ID: 23838585
[TBL] [Abstract][Full Text] [Related]
36. Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Ohene-Frempong K; Weiner SJ; Sleeper LA; Miller ST; Embury S; Moohr JW; Wethers DL; Pegelow CH; Gill FM
Blood; 1998 Jan; 91(1):288-94. PubMed ID: 9414296
[TBL] [Abstract][Full Text] [Related]
37. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.
Castro O; Brambilla DJ; Thorington B; Reindorf CA; Scott RB; Gillette P; Vera JC; Levy PS
Blood; 1994 Jul; 84(2):643-9. PubMed ID: 7517723
[TBL] [Abstract][Full Text] [Related]
38. Neurologic complications in children under five years with sickle cell disease.
Galadanci AA; DeBaun MR; Galadanci NA
Neurosci Lett; 2019 Jul; 706():201-206. PubMed ID: 31039424
[TBL] [Abstract][Full Text] [Related]
39. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course.
Brown AK; Sleeper LA; Pegelow CH; Miller ST; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1156-62. PubMed ID: 7921116
[TBL] [Abstract][Full Text] [Related]
40. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
